Literature DB >> 25870960

Autophagy in Alzheimer's disease.

Ameneh Zare-Shahabadi, Eliezer Masliah, Gail V W Johnson, Nima Rezaei.   

Abstract

Autophagy is a vesicle and lysosome-mediated degradative pathway that is essential for protein homeostasis and cell health. In particular, compared to nonneuronal cells, neurons are dependent on high basal autophagy for survival. There is emerging agreement that defects in autophagy are likely to contribute to the neurodegenerative processes in numerous diseases, including Alzheimer's disease (AD). Autophagy-lysosome defects occur early in the pathogenesis of AD and have been proposed to be a significant contributor to the disease process. Given the fact that autophagy deficits are likely major contributors to the etiology of AD, the focus of this review will be on recent studies that support a role for autophagy deficits in AD.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25870960      PMCID: PMC5039008          DOI: 10.1515/revneuro-2014-0076

Source DB:  PubMed          Journal:  Rev Neurosci        ISSN: 0334-1763            Impact factor:   4.353


  107 in total

1.  Proteasomal degradation of tau protein.

Authors:  Della C David; Robert Layfield; Louise Serpell; Yolanda Narain; Michel Goedert; Maria Grazia Spillantini
Journal:  J Neurochem       Date:  2002-10       Impact factor: 5.372

Review 2.  Alzheimer's disease.

Authors:  Henry W Querfurth; Frank M LaFerla
Journal:  N Engl J Med       Date:  2010-01-28       Impact factor: 91.245

3.  Lysosomal alkalization and dysfunction in human fibroblasts with the Alzheimer's disease-linked presenilin 1 A246E mutation can be reversed with cAMP.

Authors:  E E Coffey; J M Beckel; A M Laties; C H Mitchell
Journal:  Neuroscience       Date:  2014-01-10       Impact factor: 3.590

4.  Rapamycin treatment augments motor neuron degeneration in SOD1(G93A) mouse model of amyotrophic lateral sclerosis.

Authors:  Xiaojie Zhang; Liang Li; Sheng Chen; Dehua Yang; Yi Wang; Xin Zhang; Zheng Wang; Weidong Le
Journal:  Autophagy       Date:  2011-04-01       Impact factor: 16.016

5.  A caspase cleaved form of tau is preferentially degraded through the autophagy pathway.

Authors:  Philip J Dolan; Gail V W Johnson
Journal:  J Biol Chem       Date:  2010-05-13       Impact factor: 5.157

6.  AMP-activated protein kinase signaling activation by resveratrol modulates amyloid-beta peptide metabolism.

Authors:  Valérie Vingtdeux; Luca Giliberto; Haitian Zhao; Pallavi Chandakkar; Qingli Wu; James E Simon; Elsa M Janle; Jessica Lobo; Mario G Ferruzzi; Peter Davies; Philippe Marambaud
Journal:  J Biol Chem       Date:  2010-01-14       Impact factor: 5.157

7.  Biology and pathophysiology of the amyloid precursor protein.

Authors:  Hui Zheng; Edward H Koo
Journal:  Mol Neurodegener       Date:  2011-04-28       Impact factor: 14.195

8.  New modularity of DAP-kinases: alternative splicing of the DRP-1 gene produces a ZIPk-like isoform.

Authors:  Yishay Shoval; Hanna Berissi; Adi Kimchi; Shmuel Pietrokovski
Journal:  PLoS One       Date:  2011-03-08       Impact factor: 3.240

9.  Regulation of Toll-like receptor signaling by NDP52-mediated selective autophagy is normally inactivated by A20.

Authors:  Megumi Inomata; Shumpei Niida; Ken-ichiro Shibata; Takeshi Into
Journal:  Cell Mol Life Sci       Date:  2011-10-02       Impact factor: 9.261

10.  Nrf2 reduces levels of phosphorylated tau protein by inducing autophagy adaptor protein NDP52.

Authors:  Chulman Jo; Soner Gundemir; Susanne Pritchard; Youngnam N Jin; Irfan Rahman; Gail V W Johnson
Journal:  Nat Commun       Date:  2014-03-25       Impact factor: 14.919

View more
  71 in total

1.  Spleen tyrosine kinase (SYK) blocks autophagic Tau degradation in vitro and in vivo.

Authors:  Jonas Elias Schweig; Hailan Yao; Kyle Coppola; Chao Jin; Fiona Crawford; Michael Mullan; Daniel Paris
Journal:  J Biol Chem       Date:  2019-07-19       Impact factor: 5.157

2.  6-OHDA Induces Oxidation of F-box Protein Fbw7β by Chaperone-Mediated Autophagy in Parkinson's Model.

Authors:  Xiufeng Wang; Heng Zhai; Fang Wang
Journal:  Mol Neurobiol       Date:  2017-07-22       Impact factor: 5.590

Review 3.  Functional analyses of major cancer-related signaling pathways in Alzheimer's disease etiology.

Authors:  Jianping Guo; Ji Cheng; Brian J North; Wenyi Wei
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2017-07-08       Impact factor: 10.680

4.  Selenomethionine Mitigates Cognitive Decline by Targeting Both Tau Hyperphosphorylation and Autophagic Clearance in an Alzheimer's Disease Mouse Model.

Authors:  Zhong-Hao Zhang; Qiu-Yan Wu; Rui Zheng; Chen Chen; Yao Chen; Qiong Liu; Peter R Hoffmann; Jia-Zuan Ni; Guo-Li Song
Journal:  J Neurosci       Date:  2017-01-30       Impact factor: 6.167

5.  Increased PKR level in human CADASIL brains.

Authors:  Emmanuel Cognat; Marion Tible; Ilyes Methnani; Hugues Chabriat; Homa Adle-Biassette; Jacques Hugon; Claire Paquet
Journal:  Virchows Arch       Date:  2018-08-02       Impact factor: 4.064

Review 6.  Disorders of lysosomal acidification-The emerging role of v-ATPase in aging and neurodegenerative disease.

Authors:  Daniel J Colacurcio; Ralph A Nixon
Journal:  Ageing Res Rev       Date:  2016-05-16       Impact factor: 10.895

7.  Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model.

Authors:  Brian Spencer; Paula A Desplats; Cassia R Overk; Elvira Valera-Martin; Robert A Rissman; Chengbiao Wu; Michael Mante; Anthony Adame; Jazmin Florio; Edward Rockenstein; Eliezer Masliah
Journal:  J Neurosci       Date:  2016-07-27       Impact factor: 6.167

8.  Autophagy in Myelinating Glia.

Authors:  Jillian Belgrad; Raffaella De Pace; R Douglas Fields
Journal:  J Neurosci       Date:  2019-11-19       Impact factor: 6.167

Review 9.  Human Herpesviruses 6A and 6B in Brain Diseases: Association versus Causation.

Authors:  Anthony L Komaroff; Philip E Pellett; Steven Jacobson
Journal:  Clin Microbiol Rev       Date:  2020-11-11       Impact factor: 26.132

10.  Dihydroceramide Desaturase 1 Inhibitors Reduce Amyloid-β Levels in Primary Neurons from an Alzheimer's Disease Transgenic Model.

Authors:  Lara Ordóñez-Gutiérrez; Irene Benito-Cuesta; José Luis Abad; Josefina Casas; Gemma Fábrias; Francisco Wandosell
Journal:  Pharm Res       Date:  2018-02-06       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.